F255-0628 Screening compound: N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-1H,4H,5H-benzo[g]indazole-3-carboxamide

F255-0628 Screening compound: N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-1H,4H,5H-benzo[g]indazole-3-carboxamide
F255-0628 Screening compound: N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-1H,4H,5H-benzo[g]indazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F255-0628
N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-1H,4H,5H-benzo[g]indazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F255-0628

Molecular Formula

C28H25N5O (C28 H25 N5 O)

Compound Name

N-{4-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-1H,4H,5H-benzo[g]indazole-3-carboxamide

IUPAC name

N-{4-[2-(5-methyl-1H-13-benzodiazol-2-yl)ethyl]phenyl}-1H4H5H-benzo[g]indazole-3-carboxamide

SMILES

Cc(cc1)cc2c1[nH]c(CCc(cc1)ccc1NC(c1n[nH]c-3c1CCc1c3cccc1)=O)n2

InChI

InChI=1S/C28H25N5O/c1-17-6-14-23-24(16-17)31-25(30-23)15-9-18-7-11-20(12-8-18)29-28(34)27-22-13-10-19-4-2-3-5-21(19)26(22)32-33-27/h2-8,11-12,14,16H,9-10,13,15H2,1H3,(H,29,34)(H,30,31)(H,32,33)

InChI Key

NZZMXONUSUUNBO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14946273

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

447.54

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.199

Distribution Coefficient, logD

6.183

Water Solubility, LogSw

-5.52

Polar Surface Area

67.382

Acid Dissociation Constant (pKa)

6.56

Base Dissociation Constant (pKb)

5.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

17.90

F255-0628 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Ion Channels Focused Library (26372 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Nervous system
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Kinases
  • Ion Channels
  • Phosphatases
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F255-0628 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F255-0628?
Check Price and Availability of F255-0628, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F255-0628 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F255-0628
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F255-0628
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F255-0628 available by request